Macrogenics (MGNX) Other Non-Current Liabilities (2012 - 2026)

Macrogenics (MGNX) reported Other Non-Current Liabilities of $727000.0 for Q1 2026, down 63.06% year-over-year from $2.0 million in Q1 2025, and down 30.89% quarter-over-quarter from $1.1 million in Q4 2025.

Macrogenics (MGNX) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 12 years of Other Non-Current Liabilities data on file, last reported at $727000.0 in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $727000.0, down 63.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $727000.0 (down 63.06% YoY), and the FY2025 annual result was $1.1 million, down 46.54% from the prior year.
  • Other Non-Current Liabilities eased to $727000.0 in Q1 2026 per MGNX's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $2.0 million in Q4 2024 and troughed at $258000.0 in Q1 2022.
  • A 5-year average of $679352.9 and a median of $258000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities surged 662.79% in 2024, then sank 63.06% in 2026.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $258000.0 in 2022, then changed by 0.0% to $258000.0 in 2023, then surged by 662.79% to $2.0 million in 2024, then sank by 46.54% to $1.1 million in 2025, then sank by 30.89% to $727000.0 in 2026.
  • Business Quant data shows MGNX's Other Non-Current Liabilities at $727000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Macrogenics 260.14 Mn 193.63 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 727,000.00
Dec 31, 2025 1.05 Mn
Sep 30, 2025 1.33 Mn
Jun 30, 2025 1.67 Mn
Mar 31, 2025 1.97 Mn
Dec 31, 2024 1.97 Mn
Sep 30, 2024 258,000.00
Jun 30, 2024 258,000.00
Mar 31, 2024 258,000.00
Dec 31, 2023 258,000.00
Sep 30, 2023 258,000.00
Jun 30, 2023 258,000.00
Mar 31, 2023 258,000.00
Dec 31, 2022 258,000.00
Sep 30, 2022 258,000.00
Jun 30, 2022 258,000.00
Mar 31, 2022 258,000.00
Dec 31, 2021 258,000.00
Sep 30, 2021 258,000.00
Jun 30, 2021 258,000.00